Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
6's going something cooking! NSEH
wow 6s being eaten! NSEH
yes very nice.
It appears as though a lot is in motion for NSEH.
Looks like a strong reversal is in motion for NSEH
sure is looking good around here :)
agree
ADMD CEO excellent wants to bring company to where it belongs.
ADMD a lot coming
ADMD is solid in my opinion. People are buying and selling it and making money so that is always good. Plus its not just any regular stock because the CEO has a lot in the pipeline and if you read the most recent news you will see the pros and cons of this like any other stock in its category.
By filing the de novo submission, the Company is seeking reclassification of the product to Class II. The FDA has 120 days in which to make a decision, though the period will be extended for any time AMIC requires to respond to FDA requests for additional information. If the de novo submission is granted, the device may be immediately marketed in the United States, though the Company would have to secure funding and commercial arrangements before marketing could commence. If the de novo submission is declined, the Company will explore steps toward seeking approval for the device as a Class III medical device.
:)
ADMD CEO stepped it up a lot
I am excited for the future of ADMD
Imagine if ADMD gets FDA approved. :)
By filing the de novo submission, the Company is seeking reclassification of the product to Class II. The FDA has 120 days in which to make a decision, though the period will be extended for any time AMIC requires to respond to FDA requests for additional information. If the de novo submission is granted, the device may be immediately marketed in the United States, though the Company would have to secure funding and commercial arrangements before marketing could commence. If the de novo submission is declined, the Company will explore steps toward seeking approval for the device as a Class III medical device.
Appears to be a very solid company with a lot in the pipeline. ADMD$
Looking wonderful around here :)
I believe there is solid potential here and I never retract from that :)Happy Holidays Everyone
Now time for a big bounce :) INCC$ Happy Holidays Everyone!
ADMD appears to be a solid play imo
Bounce time ADMD
FDA approval will take this to pennies and dollars
YAHOOO ADMD
IF FDA REJECTS PHASE 2 GOES TO PHASE 3 AND CONTINUES THERE IS HIGH PROBABILITY IT WILL BE ACCEPTED
what I was saying to someone here was I see longer term potential in this one because according to the FACTS which have been made available to everyone here ADMD has filed for FDA phase 2 and if in the worst case scenario phase 2 gets rejected phase 3 will ensue. so what I was saying was that this has tremendous potential in the months ahead to bounce to new highs and depending on the approval process we could see dollars here. Some penny stocks have gotten FDA approval I cannot remember the ticker but I remember one that went from these levels to pennies and dollars based on the approval alone. I am not trying to hype anything up just speaking using the facts presented to me :) ADMD
The potential for this stock to bounce again is great I feel we have a strong winner in the months ahead
The Future Looks bright- If they do not get approval for class 2 it goes to class 3 BUT THEY STILL GET THE CHANCE AND THEY CHANGED THINGS AROUND PEOPLE SHOULD UNDERSTAND THIS
In February 2014 , the FDA rejected the Company's request for marketing clearance for the same device under Section 510(k) of the Act. The FDA determined that the device was not substantially equivalent, concluding that the device is classified by statute as a Class III medical device, unless the device is reclassified.
By filing the de novo submission, the Company is seeking reclassification of the product to Class II. The FDA has 120 days in which to make a decision, though the period will be extended for any time AMIC requires to respond to FDA requests for additional information. If the de novo submission is granted, the device may be immediately marketed in the United States , though the Company would have to secure funding and commercial arrangements before marketing could commence.
READ IT CAREFULLY BEFORE YOU SPECULATE
Pennystock with FDA approval process appears undervalued to me
people want shares
Huge kaboomage coming
We have room to run up now according to the charts :) ADMD$
EVERYONE COMING BACK IN HERE WEEEE ADMD $
ADMD BOUNCE 13's Going
TIME TO MOVE NORTH! ADMD 13's clearing :)
ADMD Ready to bust a big move north
KABOOMAGE COMING ADMD
A LOT OF NEWS COMING HAHAHA YOU DONT HAVE TO BUY THOUGH JUST SAYING THIS COMPANY IS MAKING A SERIOUS TURN AROUND JUST SIT TIGHT AND WATCH IT HAPPEN IMO
PEOPLE WANT SHARES OF THIS BECAUSE ITS A GEM!